VP
Vinci Pharmaceuticals, Inc.
SEC filingOther Health Care · Avon by the Sea, NJ
Amount raised$20.2Msold at filing
Total offering$25.3M$5.1M still open
Investors in the raise53count reported to the SEC
FiledJan 26, 2026first sale Jan 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sarah HassanDirector
Richard LindstromDirector
Sigurd KirkDirector
Neil Austrian Jr.Director
Philip GioiaExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.